Global Bio-Pharma CMO Market Report -- New Report by Koncept Analytics

June 10, 2010 - PRLog -- The big-pharma companies are increasingly outsourcing their production of drugs to contract manufacturing organizations (CMOs) solely to reduce cost of production, working capital requirement, and time-to-market, or to obtain a specific expertise not available in-house. The biggest factor to drive the growth of CMOs in the pharmaceutical industry is the growing need of state-of-the-art process & production technologies, which have  
proven highly effective in meeting regulatory requirements.

The global market for bio-pharma has grown at a CAGR of 11.2% over the last few years. The share of the CMO market of the total bio-pharma market has also increased over 2001 to -2008. The Bio-Pharma CMO market can be segmented into Mammalian CMO market and Microbial CMO market. The largest capacity share of the bio-pharma CMO market is held by the Mammalian CMO market.

The main growth driver of the bio-pharma CMO market is the increasing outsourcing trend among the bio-pharma manufacturers as a result of stringent regulatory environment. However, factors like global economic crisis, intellectual property risk, increasing regulatory cost, and lack of integrated CMOs are also acting as a roadblock in the path of overall industry growth, which are highly recommended to be solved to grow in the long term.

The report broadly includes the following

1. Overview

1.1 Global Pharmaceutical Market
1.2 Global Bio-Pharmaceutical Market
1.3 Global Contract Outsourcing Market

2. Global CMO Bio-Pharma Market

2.1 Overview
2.2 Market Size
2.3 Segmentation

3. India- Outsourcing Hub

3.1 Overview
3.2 India’s Advantage
3.3 Key Issues

4. Market Movements

4.1 Key Trends
4.2 Growth Drivers
4.3 Challenges

5. Competitive Landscape

6. Company Profiles

6.1 Lonza
6.2 Jubilant Organosys
6.3 Piramal Healthcare
6.4 Patheon Inc.

7. Market Outlook

List of Tables

Dependent & Independent Variables, 2001– 2009
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Figures

Global Pharmaceutical Market, 2003-2008
Global Pharmaceutical Market by Region, 2008
Global Bio-Pharmaceutical Market, 2002-2008
Bio-Pharmaceutical Commercial Product Sales, 2002-2008
Global Pharmaceutical Contract Outsourcing Market, 2007-2008
Utilization of Outsourcing across Value Chain
Global CMO Bio-Pharma Market Size, 2000-2009
Segmentation of Bio-Pharma CMO Market
Mammalian Cell Culture Capacity, 2006-2009E
Microbial CMO Market by Capacity (Fermenter Volume), 2003-2009E
Indian Custom Manufacturing Outsourcing Market, 2007-2010E
Cost Efficiency Attractiveness in India
Skilled Manpower Attractiveness in India
No. of USFDA Approved Plants Comparison
Regulatory Environment Attractiveness in India
Comparison of Corporate Income Tax Rates by Country
Trend in Outsourcing to Asia, 2009
Bio-Pharma CMO Market Share, 2001 & 2008
Declining Internal Custom Manufacturing Capacity
World Population, 2000-2009
Pharma Market Potential Growth by Region, 2009-2013
Global Generic Market, 2008-2014
Global Bio-Pharma Industry Capacity Distribution, 2009
CMO & PDC Cell Culture Bioreactor Capacity distribution, 2004-2008
Lonza Business Revenues, 2005-2009
Jubilant Organosys Business Revenues, 2005-2009
Piramal Healthcare Business Revenues, 2005-2009
Patheon Business Revenues, 2005-2009
Global Bio-Pharma CMO Market Forecast, 2009-2013F

For more details, please visit http://www.konceptanalytics.com/reportDetail.aspx?reportI...

To know more, http://www.konceptanalytics.com/

# # #

Koncept Analytics, founded in 2005, works with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.